Eli Lilly and Company ( LLY) - Key Metrics

LLY Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $21.48 $7.39 ? ?
2025Q3 $19.62 $6.22 $9.85 $9.60
2025Q2 $17.33 $6.30 $3.44 $1.43
2025Q1 $14.17 $3.07 $1.85 -$1.78

LLY Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 20.30% 36.36
2025Q3 24.10% 30.65
2025Q2 23.80% 30.91
2025Q1 48.79% 67.20

LLY Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 0.37% ?
2025Q4 0.07% 0.14%
2025Q3 1.26% 0.20%
2025Q2 0.18% 0.19%
2025Q1 -0.22% 0.18%

LLY

List: Contenders

Price: $1,131.42

52 week price:
623.78
1166.29

Dividend Yield: 0.61%

5-year range yield:
0.61%
1.79%

Forward Dividend Yield: 0.61%

Payout Ratio: 63.73%

Payout Ratio Range:
-16062.50%
328.65%

Dividend Per Share: 6.92 USD

Earnings Per Share: 28.18 USD

P/E Ratio: 35.03

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.6 million

Ebitda: 758.9 million

Market Capitalization: 1.1 trillion

Average Dividend Frequency: 4

Years Paying Dividends: 55

DGR3: 16.91%

DGR5: 16.13%

DGR10: 11.60%

DGR20: 7.34%

Links: